Progestin Market adoption in the US is encouraged by the use of hormonal contraceptives and long-acting reversible contraceptive methods that contain progestins. The Progestin Market was valued at US$ 11.36 billion in 2025 and is projected to reach US$ 18.08 billion by 2034, registering a CAGR of 5.3% during the forecast period from 2026 to 2034. Market growth is supported by demand for...